SCOPE 2 – Still Answering the Unanswered Questions in Oesophageal Radiotherapy? SCOPE 2: a Randomised Phase II/III Trial to Study Radiotherapy Dose Escalation in Patients with Oesophageal Cancer Treated with Definitive Chemoradiation with an Embedded Phase II Trial for Patients with a Poor Early Response using Positron Emission Tomography/Computed Tomography-Reference-Cited by-同舟云学术

SCOPE 2 – Still Answering the Unanswered Questions in Oesophageal Radiotherapy? SCOPE 2: a Randomised Phase II/III Trial to Study Radiotherapy Dose Escalation in Patients with Oesophageal Cancer Treated with Definitive Chemoradiation with an Embedded Phase II Trial for Patients with a Poor Early Response using Positron Emission Tomography/Computed Tomography

Published:2022-07 Issue:7 Volume:34 Page:e269-e280
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Bridges S.,Thomas B.,Radhakrishna G.,Hawkins M.,Holborow A.,Hurt C.,Mukherjee S.,Nixon L.,Crosby T.,Gwynne S.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference58 articles.

1. Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial;Crosby;Lancet Oncol,2013

2. NEOSCOPE: a randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma;Mukherjee;Eur J Cancer,2017

3. Driving developments in UK oesophageal radiotherapy through the SCOPE trials;Gwynne;Radiat Oncol,2019

4. Randomized study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer (ARTDECO Study);Hulshof;J Clin Oncol,2021

5. Outcome of weekly carboplatin–paclitaxel-based definitive chemoradiation in oesophageal cancer in patients not considered to be suitable for platinum–fluoropyrimidine-based treatment: a multicentre, retrospective review;Owens;Clin Oncol,2020

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. United Kingdom and Ireland Oesophagogastric Cancer Group Cancer Update 2023;Clinical Oncology;2024-09

2. Advances in diagnosis and management of cancer of the esophagus;BMJ;2024-06-03

3. Esophagogastric Cancer;Hematology/Oncology Clinics of North America;2024-06

4. Multi-disciplinary management of esophageal carcinoma: Current practices and future directions;Critical Reviews in Oncology/Hematology;2024-05

5. Treatment Outcomes and Risk Factors for Incomplete Treatment after Definitive Chemoradiotherapy for Non-Resectable or Metastatic Esophageal Cancer;Cancers;2023-11-15